News

Article

AAO 2023: CoFi company updates and partnership with CareCredit

Sean Hanlon, CEO of CoFi, spoke with Ophthalmology Times about company updates as well as their integration with CareCredit at this year's American Academy of Ophthalmology meeting.

Sean Hanlon, CEO of CoFi, spoke with Ophthalmology Times about company updates as well as their integration with CareCredit at this year's American Academy of Ophthalmology meeting.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Sean Hanlon:

Hi, I'm Sean Hanlon. I'm the CEO of CoFi, and I'm here at the American Academy of Ophthalmology meeting in San Francisco. It's a terrific meeting. Very exciting. We're just getting started today. CoFi is a younger company, we're almost 4 years old, and we enable patients to pay multiple providers involved in a, in a procedure at 1 time. So for example, for a cataract procedure, the patient can pay the surgeon, surgery center and a comanaging optometrist in completely separate payments but all happening at once. We launched our product about 2.5 years ago and we're approaching 4,000 surgeons and optometrists on our platform and a growing number of surgery centers. And I'm really excited because the latest innovation at CoFi is an integration with CareCredit, which will be, which we've already announced, and will be rolling out starting January first. This integration is pretty innovative, it enables multiparty patient financing. So patients can have one financing event or one loan for an elective procedure, and each party compliantly receives their respective portion. So, again, the surgeon, the surgery center, comanaging optometrist, anesthesia provider. And so CareCredit is also very excited to be bringing this to market because it's something that their customers have been asking about for quite a bit of time.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.